GABA(A) versus GABA(B) in catatonia.
Carroll
Brendan T
BT
Thomas
Christopher
C
Tugrul
Karen C
KC
Coconcea
Cristonel
C
Goforth
Harold W
HW
D001008:Anxiety Disorders / Q000150:complications / Q000503:physiopathology; D002389:Catatonia / Q000503:physiopathology*; D002637:Chest Pain / Q000150:complications / Q000503:physiopathology; D003693:Delirium / Q000209:etiology / Q000523:psychology; D018757:GABA Modulators / Q000009:adverse effects; D006801:Humans; D008140:Lorazepam / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011963:Receptors, GABA-A / Q000502:physiology*; D018080:Receptors, GABA-B / Q000502:physiology*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology / Q000523:psychology
D018757:GABA Modulators; D011963:Receptors, GABA-A; D018080:Receptors, GABA-B; D008140:Lorazepam